|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 美国临床生化科学院检验医学实践指南:睾丸、前列腺、结直肠、乳腺及卵巢癌肿瘤标志物的应用显示文摘经美国临床生化科学院(NCAB)授权,由鄢盛恺教授组织学者、专家翻译审定2009年NCAB检验医学实践指南:睾丸、前列腺、结直肠、乳腺及卵巢癌中肿瘤标志物的应用单行本(Catharine M.Sturgeon教授和Eleftherios P.Diaman-dis教授编辑)。该指南包含第1至6章共6部分内容,参加指南制订的专家阵容强大,分别从临床及检验角度对睾丸、前列腺、结直肠、乳腺及卵巢癌中肿瘤标志物的检测与临床应用方面的问题进行了详细阐述与说明,是目前国内外在肿瘤实验诊断方面的纲领性应用文件。不仅适合广大检验人员、临床医护人员学习使用,也非常适合相关仪器试剂生产厂商研发应用。本指南由刘洋、薛丽、林文涛、李江、梁红艳、顾兵、潘世扬、郑磊等翻译,姜晓峰、沈文梅、田亚平、鄢盛恺审校,最后由鄢盛恺统稿审定。本指南的翻译出版,不仅有助于我国检验人员和医护人员合理的检测和应用睾丸、前列腺、结直肠、乳腺及卵巢癌肿瘤标志物,对我国检验医学指南的编写与应用也有一定的借鉴作用。本刊特在本期刊发,以飨广大读者。 | 鄢盛恺 Ulf-Hkan Stenman Rolf Lamerz Leendert H.Looijenga Nils Brünner Michael J.Duffy Caj Haglund Mads Holten-Andersen Hans JФrgen Nielsen Francisco J.Esteva Nadia Harbeck Daniel F.Hayes Rafael Molina Daniel W.Chan Robert C.Bast Jr Ie-Ming Shih Lori J.Sokoll Gyrgy Slétormos 刘洋 梁红艳 姜晓峰 田亚平 薛丽 林文涛 顾兵 潘世扬 沈文梅 郑磊 李江 | 2012 | 临床检验杂志2012，30，2： | 32 |
| 2 | 多环芳烃污染区域氧化多环芳烃的来源、迁移转化和毒性危害显示文摘本文阐明了在对高浓度多环芳烃污染区域进行风险评估和修复过程中,氧化多环芳烃是不容忽视的重要污染物。我们通过对自己的研究成果和公开发表资料的综合分析,发现在这些地方氧化多环芳烃的量较大,但并未受到足够重视。这些氧化多环芳烃是通过多环芳烃转化而来的,滞留时间也较长。许多修复方法会加速多环芳烃的降解,从而导致在环境中的氧化多环芳烃浓度升高。此外,我们发现尽管氧化多环芳烃与通过诱变和致癌等多环芳烃常见的毒害有区别的方式产生毒性,但他们对人类和环境也是有害的。我们还有数据支持以下假说:在环境中,具有极性的氧化多环芳烃比多环芳烃稳定性差,更易通过受污染地区的地表水和地下水扩散。因此在受多环芳烃污染区域,氧化多环芳烃应该纳入监测项目当中,而其它毒性相关成分如带硝基的多环芳烃和氮杂环芳烃等则不必纳入监洲项目当中。因为氧化多环芳烃有可能在多环芳烃发生降解的时候形成,而且它们的环境行为是完全不同的,也很难通过多环芳烃浓度来预测氧化多环芳烃的含量。 | Staffan Lundstedt Paul A.White Christine L.Lemieux Krista D.Lynes Iain B.Lambert Larsberg Peter Haglund Mats Tysklind 王丽平 | 2007 | AMBIO-人类环境杂志2007，36，6： | 11 |
| 3 | Quality of life following laparoscopic Nissen fundoplication: Assessing short-term and long-term outcomes显示文摘AIM: To investigate the quality of life following lapa-roscopic Nissen fundoplication by assessing short-term and long-term outcomes. METHODS: From 1992 to 2005, 249 patients under-went laparoscopic Nissen fundoplication. Short-term outcome data including symptom response, side effects of surgery, endoscopy, and patient's perception of over-all success were collected prospectively. Long-term out-comes were investigated retrospectively in patients witha median follow-up of 10 years by assessment of reflux symptoms, side effects of surgery, durability of antire-flux surgery, need for additional treatment, patient's perception of success, and quality of life. Antireflux sur-gery was considered a failure based on the following criteria: moderate to severe heartburn or regurgitation; moderate to severe dysphagia reported in combination with heartburn or regurgitation; regular proton pump inhibitor medication use; endoscopic evidence of erosive esophagitis Savary-Miller grade 1-4; pathological 24-h pH monitoring; or necessity to undergo an additional surgery. The main outcome measures were short-and long-term cure rates and quality of life, with patient sat-isfaction as a secondary outcome measure. RESULTS: Conversion from laparoscopy to open sur-gery was necessary in 2.4% of patients. Mortality was zero and the 30-d morbidity was 7.6% (95%CI: 4.7%-11.7%). The median postoperative hospital stay was 2 d [interquartile range (IQR) 2-3 d]. Two hundred and forty-seven patients were interviewed for short-term analysis following endoscopy. Gastro-esophageal reflux disease was cured in 98.4% (95%CI: 95.9%-99.6%) of patients three months after surgery. New-onset dysphagia was encountered postoperatively in 13 patients (6.7%); 95% reported that the outcome was better after antireflux surgery than with preopera-tive medical treatment. One hundred and thirty-nine patients with a median follow-up of 10.2 years (IQR 7.2-11.6 years) were available for a long-term evalu-ation. Cumulative long-term cure rates were 87.7% (81.0%-92.2%) at 5 years and 72.9% (64.0%-79.9%) at 10 years. Gastrointestinal symptom rating scores and RAND-36 quality of life scores of patients with treatment success were similar to those of the general population but significantly lower in those with failed antireflux surgery. Of the patients available for long-term follow-up, 83% rated their operation a success. CONCLUSION: For the long-term, our results indicate decreasing effectiveness of laparoscopic antirefluxsurgery, although most of the patients seem to have an overall quality of life similar to that of the general population. | Ilmo Kellokumpu Markku Voutilainen Caj Haglund Martti Frkkil Peter J Roberts Hannu Kautiainen | 2013 | World Journal of Gastroenterology2013，19，24： | 7 |
| 4 | Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma显示文摘AIM: To study whether examination of CagA antibodies could increase the odds ratio for gastric cancer in a casecontrol study, and how often other serum markers of gastric cancer risk could be found in Helicobacter pylorinegative patients.METHODS: H pylori CagA and parietal cell antibodies(PCAs), and serum pepsinogen Ⅰ (SPGI) levels were compared between patients with gastric cancer and controls who received endoscopic examination due to reasons other than gastrointestinal malignancy.RESULTS: The odds ratio (OR) for gastric cancer was2.9 (95% CI 1.4-5.8) in H pylori+ patients, and 2.4 (95%CI 1.2-4.9) in CagA+ patients. When results of H pylori and CagA antibodies were combined, OR increased to5.0 (95% CI 2.5-10.0). Furthermore, if cardia cancer patients were excluded, the OR increased to 6.8 (95% CI3.1-14.8). Among patients with a low SPGI level, the OR was 12.0 (95% CI 4.1-35.3). However, the risk was significant only in the older age group. The number of patients with low SPGI was significantly higher in H pylori-/CagA+ patients as compared to other cancer patients.CONCLUSION: Examination of both H pylori and CagA antibodies increases the OR for gastric cancer in our casecontrol study. CagA antibodies are important in detecting previous H pylori infection in advanced atrophic gastritis or cancer when spontaneous decline of H pylori antibodies occurs. SPGI may be helpful in screening elderly gastric cancer patients. | Arto Kokkola Johanna Louhimo Pauli Puolakkainen Henrik Alfthan Caj Haglund Hilpi Rautelin | 2005 | World Journal of Gastroenterology2005，11，7： | 6 |
| 5 | Contribution of precursor compounds to the release of per-and polyfluoroalkyl substances(PFASs) from waste water treatment plants(WWTPs)显示文摘Per-and polyfluoroalkyl substances(PFASs) are ubiquitous in sludge and water from waste water treatment plants, as a result of their incorporation in everyday products and industrial processes. In this study, we measured several classes of persistent PFASs,precursors, transformation intermediates, and newly identified PFASs in influent and effluent sewage water and sludge from three municipal waste water treatment plants in Sweden, sampled in 2015. For sludge, samples from 2012 and 2014 were analyzed as well.Levels of precursors in sludge exceeded those of perfluoroalkyl acids and sulfonic acids(PFCAs and PFSAs), in 2015 the sum of polyfluoroalkyl phosphoric acid esters(PAPs) were 15–20 ng/g dry weight, the sum of fluorotelomer sulfonic acids(FTSAs) was 0.8–1.3 ng/g,and the sum of perfluorooctane sulfonamides and ethanols ranged from non-detected to 3.2 ng/g. Persistent PFSAs and PFCAs were detected at 1.9–3.9 ng/g and 2.4–7.3 ng/g dry weight, respectively. The influence of precursor compounds was further demonstrated by an observed substantial increase for a majority of the persistent PFCAs and PFSAs in water after waste water treatment. Perfluorohexanoic acid(PFHxA), perfluorooctanoic acid(PFOA), perfluorohexane sulfonic acid(PFHxS), and perfluorooctane sulfonic acid(PFOS)had a net mass increase in all WWTPs, with mean values of 83%, 28%, 37% and 58%,respectively. The load of precursors and intermediates in influent water and sludge combined with net mass increase support the hypothesis that degradation of precursor compounds is a significant contributor to PFAS contamination in the environment. | Ulrika Eriksson Peter Haglund Anna K?rrman | 2017 | Journal of Environmental Sciences2017，29，11： | 5 |
| 6 | Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update显示文摘 | M.J. Duffy R. Lamerz C. Haglund A. Nicolini M. Kalousová L. Holubec C. Sturgeon | 2014 | Int. J. Cancer2014，，11： | 3 |
| 7 | Carbonic anhydrase enzymes Ⅱ, Ⅶ, Ⅸ and Ⅻ in colorectal carcinomas显示文摘AIM To investigate expression of four alpha-carbonic anhydrases(CAs) in colorectal carcinomas(CRC) and compare the results with patients' survival.METHODS Colorectal carcinoma samples from 539 CRC patients and control tissues were arranged as tissue microarrays and analyzed with antibodies against CA Ⅱ, CA Ⅶ, CA Ⅸ, and CA Ⅻ. Intensity and extent of staining were both scored from 0 to 3 in each sample. These enzyme expression levels were then correlated to patients' survival and clinicopathological parameters, which were tumor differentiation grade and stage, site of tumor, patients' age, and gender. Kaplan-Meier analysis and Cox regression hazard ratio model were used to analyze survival data. RESULTS CA Ⅱ and CA Ⅻ staining intensities correlated with patients' survival in that higher expression indicated poorer prognosis. In Cox regression analysis one unit increase in the CA Ⅱ intensity increased the hazard ratio to 1.19 fold(CI: 1.04-1.37, P = 0.009). A significant correlation was also found when comparing CA Ⅻ staining intensity with survival of CRC patients(HR = 1.18, 95%CI: 1.01-1.38, P = 0.036). The extent of CA Ⅻ immunostaining did not correlate to the patients' survival(P = 0.242, Kaplan-Meier analysis). A significant interaction between age group and extent of the CA Ⅱ staining was found. Increased extent of CA Ⅱ had a significant hazard ratio among patients 65 years and older(1.42, 95%CI: 1.16-1.73, P = 0.0006). No correlations were found between CA Ⅶ(intensity P = 0.566, extent P = 0.495, Kaplan-Meier analysis), or CA Ⅸ(intensity P = 0.879, extent P = 0.315, KaplanMeier analysis) immunostaining results and survival, or the other parameters. CONCLUSION The present findings indicate that CA Ⅱ and CA Ⅻ could be useful in predicting survival in CRC. | Pia Viikil? Antti J Kivel? Harri Mustonen Selja Koskensalo Abdul Waheed William S Sly Jaromir Pastorek Silvia Pastorekova Seppo Parkkila Caj Haglund | 2016 | World Journal of Gastroenterology2016，22，36： | 3 |
| 8 | 大型藻类在东部非洲污水中去除营养物质的潜在利用价值显示文摘为调查用大型藻类净化东部非洲村庄生活污水的可能性,进行了初步研究。研究工作在坦桑尼亚桑给巴尔的Unguja岛进行。在Unguja东海岸建有海滨饭店的村庄外面调查了潮间地带海藻的多样性。在排污口附近采集海水样品以分析营养物质(氮和磷)。分析了14种大型藻类的生长特征和营养物的吸收速率,而且选择其中3种进行了污水处理模型系统的深入研究。尚未发现对大型藻种类组成有何影响。在所选的3种藻类中发现对氨、硝酸盐和磷酸盐的吸收速率很高。对于最佳吸收效率,营养物的负荷及组成(主要是氮:磷值)都是变化的。我们的结论认为,当地大型藻类有利于去除营养物质,同时建议在该地区利用由长有大型藻类的罐或池组成的简易系统进行小规模的污水净化。 | Kurt Haglund Jessica Lindstrm 沈英娃 | 1995 | 人类环境杂志1995，24，7： | 2 |
| 9 | 被多氯二苯并二恶英/呋喃以及其它多氯代芳香化合物污染土壤的处理方法显示文摘本文综述了处理被多氯代芳香化合物,尤其是被二恶英和呋喃(PCDD/Fs)污染土壤的方法。与其它土壤污染物所不同的是PCDD/Fs与土壤颗粒紧密结合,这严重削弱了大多数水处理过程的效果,也使得除传统方法以外(填埋法、固化/稳定化、原位玻璃化技术)没有几种切合实际的选择方案。焚化法的应用时间很长,并且仍是最有效的处理技术,清除效率超过99.9999%。但是超临界水氧化法、碱性催化分解法、蒸馏法和其它多种萃取技术的清除效率也可超过95%,例如溶剂和液化气体以及亚临界水提取等。这些替代技术中的很多种可能比焚化法更廉价,有可能适用于被二恶英中度污染的土壤。然而,许多方法仍然处于发展初期,需要进行更多的试验评估其真正的潜力。 | Peter Haglund 王大伟 | 2007 | AMBIO-人类环境杂志2007，36，6： | 2 |
| 10 | Systemic mediator released from the gut in critical illness显示文摘 | Haglund U | 1993 | Cirt Care MED1993，21，2： | 1 |
| 11 | Analysis of halogenated polycyclic aromatic hydrocarbons in urban air, snow and automobile exhaust 显示文摘 | HAGLUND P ALSBERG T BERHMAN A | 1987 | Chemosphere1987，16，： | 1 |
| 12 | Two-dimensional current percolation in nanocrystalline vana- dium dioxide films 显示文摘 | Rozen John Lopez Rene Haglund R F | 2006 | Applied Physics Letters2006，88，08： | 1 |
| 13 | Malignancy in pheochromocytomas显示文摘 | Salmenkivi K Heikkila P Haglund C | 2004 | APMIS2004，112，9： | 1 |
| 14 | Inflammatory mediators in intervertebral disk degeneration and discogenic pain显示文摘 | Wuertz K Haglund L | 2013 | Global Spine J2013，3，3： | 1 |
| 15 | Clinical utility of biochemical markers in colorectal cancer:European Group on Tumour Markers(EGTM)guidelines显示文摘 | Duffy M J van Dalen A Haglund C | 2003 | Eur J Cancer2003，39，6： | 1 |
| 16 | Effects of fish oil alone and combined with long chain (n-6) fatty acids on some coronary risk factors in male subjects显示文摘 | Haglund O Wallin R Wretling S | 1998 | J Nutr Bio- chem1998，9，11： | 1 |
| 17 | The relevance of WHO injury surveillance guidelines for evaluation: learning from the aboriginal community-centered injury surveillance system (ACCISS) and two institution-based systems 显示文摘 | Auer AM Dobmeier TM Haglund B J et M | 2011 | BMC Public Heahh2011，11，： | 1 |
| 18 | A population - based study on the incidence and possible pre - and perinatal etiologic risk factors of biliary atresia显示文摘 | Fischler B Haglund B Hjern A | 2002 | J Pediatr2002，141，2： | 1 |
| 19 | Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden显示文摘 | Valentine WJ Aagren M Haglund M | 2011 | ScandJ Public Health2011，39，1： | 1 |
| 20 | The role of ubiquitylation in receptor endocytosis and endosomal sorting显示文摘 | Haglund K Dikic I | 2012 | J Cell Sci2012，125，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员